Radiotherapy plus temozolomide

DRUG3 trials

Sponsors

Peking Union Medical College Hospital, Institut de cancérologie Strasbourg Europe, Yingjuan Zheng

Conditions

GlioblastomaGlioma (Any Grade) in the BrainPituitary Adenomas

Phase 2

The Effect of Chemoradiotherapy in Patients With Refractory Pituitary Adenomas

Peking Union Medical College HospitalPituitary Adenomas

Start: 2020-02-10End: 2023-12-01Target: 150Updated: 2020-01-28

Study on The Sensitizing Effect of Sonodynamic Therapy on The Treatment of Brainstem Glioma With Radiotherapy and Chemotherapy and Survival Analysis

Enrolling by invitationNCT06999148

Yingjuan ZhengGlioma (Any Grade) in the Brain

Start: 2024-10-01End: 2028-05-01Target: 216Updated: 2025-05-31

Phase 3

Study of Adding or Not Liposomal Transcrocetin (L-TC) With Concomitant HypoFractionated Radiation ThErapy and TEmozolomide in Newly Diagnosed GLioblastoma (GBM) Patients

Not yet recruitingNCT06477939

Institut de cancérologie Strasbourg EuropeGlioblastoma

Start: 2025-01-01End: 2032-12-31Target: 554Updated: 2024-06-27